Semaglutide 5 MG – GLP-1 Receptor Agonist for Metabolic & metabolic studies Research

Product Description

Semaglutide – GLP-1 Analog Peptide for Appetite and Glucose Regulation Studies

Composition: 5 mg Semaglutide (lyophilized peptide powder)
Category: Peptide
Form: Vial with freeze-dried powder
Administration: Subcutaneous research application (requires reconstitution)

What is Semaglutide?

Semaglutide is a long-acting GLP-1 (Glucagon-Like Peptide-1) receptor agonist that mimics the activity of the endogenous incretin hormone GLP-1.
It associated with insulin secretion in response to glucose, is associated with glucagon release, slows gastric emptying, and investigated for influence on satiety.
These mechanisms make Semaglutide a leading compound in metabolic and obesity research.

In both preclinical and clinical research, Semaglutide has shown remarkable potential for influencing glucose regulation, modulating body fat, and supporting overall cardiometabolic parameters.

➡️ Ideal for research on appetite regulation, glucose metabolism studies, and energy balance.

Key Research Findings

• satiety signaling: binds to GLP-1 receptors in the hypothalamus to influence satiety pathways and studied for potential effects on satiety.
• metabolic studies: Demonstrated in studies to significantly studied for effects on body fat and studied for potential effects on body composition.
• glycemic parameters Regulation: investigated for influence on insulin pathway research and associated with stable glucose levels.
• Cardiometabolic Support tissueth: Shown to support influenced lipid metabolism and cardiovascular markers.
• Long-Acting Effect: Its extended half-life allows for once-weekly dosing protocols in research settings.

Mechanism of Action

Semaglutide binds to and binds to the GLP-1 receptor, leading to a cascade of metabolic effects that associated with glucose-dependent insulin secretion and satiety.
This action also investigated for modulation of glucagon release, delays gastric emptying, and influences appetite-regulating centers in the brain.
Its prolonged activity results from a structural modification that investigated for influence on binding affinity and resistance to enzymatic degradation.

Dosage and Application

Reconstitute with bacteriostatic water before use.

Commonly referenced research protocols: 0.25 – 1.0 mg per application, used in subcutaneous research models 1–2 times weekly depending on study protocol and research objective.

Store the reconstituted solution in a refrigerator and use within 30 days.

Storage Instructions

• Store at 2–8 °C (36–46 °F)
• Protect from light and moisture
• Do not freeze
• Avoid temperature fluctuations

Why Choose Semaglutide?

Semaglutide stands as one of the most well-characterized and effective GLP-1 analogs in metabolic research.
Its proven dual action on weight control and glucose regulation makes it an indispensable compound for studies in obesity, diabetes, and cardiometabolic parameters.
The extended half-life and predictable pharmacokinetic profile allow precise, consistent data collection in long-term studies.

Explore the potential of Semaglutide 5 mg for advanced research in metabolic regulation, satiety signaling, and endocrine function.

Technical Specifications

• Product Code: SEMAGLUTIDE-5MG
• Purity: ≥98% (HPLC)
• Form: Lyophilized powder
• Storage: –20 °C (before reconstitution), 2–8 °C (after reconstitution)
• Stability: 2 years lyophilized, 30 days reconstituted when properly stored

Quality Assurance

Every batch undergoes rigorous validation including:

• HPLC analysis for purity verification
• Mass spectrometry for molecular identity confirmation
• Endotoxin and sterility testing for research-grade consistency

References and Further Reading

For additional information, refer to peer-reviewed publications available through PubMed and related databases covering GLP-1 receptor agonists, metabolic regulation, and obesity research.
All peptides are produced according to current research standards and laboratory best practices.